Manufacturing Change Must Be Validated Before Drug Distribution - FDA Rule
This article was originally published in The Tan Sheet
Executive Summary
Drug companies must validate that a change in manufacturing has not significantly altered a drug product prior to distribution of the product following the change, FDA's proposed rule on "Supplements and Other Changes to an Approved Application" states.